Global Immunotherapy Drugs Market, By Type (Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha and Beta, Interleukins and Other Drugs), Application (Hospitals, Clinics and Other End Users)-Industry Trends and Forecast to 2028
Merck & Co., Inc.’s PD-1 inhibitor, pembrolizumab, has a substantial lead among the leading immunotherapy medications on the market. According to a study published in the International Journal of General Medicine in 2018, global mortality from many noncommunicable diseases (NCDs) or chronic diseases continues to rise, with a disproportionately larger impact in low-middle income countries (LMIs), with chronic diseases accounting for nearly 75% of global deaths.
Due to their high specificity and fewer side effects, as well as an increased focus on tailored therapies, industry activities, and the growing prevalence and patient pool of target diseases, the “monoclonal antibodies” segment of the type of drug holds the largest share of the immunotherapy drugs market. According to Zion Market Research, the immunotherapy pharmaceuticals market was valued at USD 181.75 billion in 2021 and is predicted to reach USD 434.18 billion by 2028, growing at a CAGR of 11.5 percent over the forecast period of 2022 to 2028.
Immunotherapy medicines are used to either strengthen or weaken the immune system. They function by stimulating the body’s immune system and causing an immunological response that aids in the creation of antibodies. They are most commonly used to treat cancer. Antibodies that are produced in response to an antigen are capable of killing cancerous or tumour cells.
Immunotherapy medications are becoming more popular than traditional treatment methods
According to study, immunotherapies can be used as a supplement to existing treatments in severe COVID-19 cases. Immunotherapies based on inflammatory cytokine neutralisation, immunomodulation, and passive viral neutralisation might reduce inflammation, inflammation-associated lung damage, and viral load while avoiding ICU admission and mechanical ventilation, accelerating market growth even further.
Cancer, autoimmune, and viral disorders are all on the rise.
In 2018, over 1,735, 350 new cancer cases were diagnosed in the United States, according to the National Cancer Institute. There are 439.2 new cancer cases per 100,000 men and women each year, which is expected to fuel the demand for immunotherapy medications.
In addition, the rising demand for tailored medications and the advancement of low-cost nanoparticles for delivering immunotherapies are providing prospective prospects for the immunotherapy pharmaceuticals market to grow in the next years.
On the other hand, timing constraints, side effects, and manufacturing challenges are expected to stymie the immunotherapy pharmaceuticals market’s growth throughout the forecast period. However, rising immunotherapy treatment expenses, geographical differences, and a lack of insurance coverage may pose additional challenges to the immunotherapy pharmaceuticals market’s expansion in the near future.
This immunotherapy drugs market report details recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, and geopolitical analysis. Contact Zion Industry Research for an Analyst Brief to learn more about the immunotherapy medications market. Our team will assist you in making an informed market choice to achieve market growth.
Impact of Covid-19 on the Market for Immunotherapy Drugs
The COVID-19 had a beneficial effect on the market for immunotherapy medications. COVID-19 has a favourable impact on the immunotherapy pharmaceuticals sector because various companies are currently working on developing immunotherapy-based medications or vaccines for COVID-19. In collaboration with Pfizer Inc., BioNTech SE is now conducting phase III clinical research in healthy volunteers to assess the safety, tolerability, and immunogenicity of BNT162b2 against COVID-19.
Market Scope and Size for Immunotherapy Drugs Worldwide
The market for immunotherapy medications is divided into types and applications. The growth of these segments will aid in the analysis of low growth segments in the industries, as well as providing users with a comprehensive market overview and industry insights to assist them in making strategic decisions for finding core market applications.
● Monoclonal Antibodies
● Adult Vaccines
● Checkpoint Inhibitors
● Interferons Alpha and Beta
Regional Market Analysis/Insights for Immunotherapy Drugs
The countries covered in the immunotherapy drugs market report are the United States, Canada, and Mexico in North America, Germany, France, the United Kingdom, the Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and the Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, and the Philippines, and the Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, the United Arab Emirates, South Africa, Egypt, Israel.
The following are some of the top players in the immunotherapy medications market:
• Abbott (US)
• PerkinElmer Inc. (US)
• Illumina, Inc. (US)
• QIAGEN (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Novartis AG (Switzerland)
• AstraZeneca (UK)
• Pfizer Inc. (US)
• Sanofi (France)
• Johnson & Johnson Services, Inc. (India)
About Us :
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database.